查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1466084

委外研发机构服务市场：按类型、研究阶段、治疗领域、分子类型、最终用户 - 2024-2030 年全球预测

Contract Research Organization Services Market by Type (Clinical Research Services, Consulting Services, Data Management Services), Trial Phase (Phase I, Phase II, Phase III), Therapeutic Area, Molecule Type, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年药物委外研发机构服务市场规模为887.8亿美元，预计2024年将达982.8亿美元，2030年将达1842.1亿美元，复合年增长率为10.98%。

委外研发机构(CRO) 服务包括为製药、生物技术和医疗设备业提供的各种委託支援选项，用于药物开发、临床试验管理和上市后监测。这些组织提供监管提交指导、临床业务、资料管理、统计分析、医学写作以及将医疗产品推向市场的复杂过程所需的其他功能方面的专业知识。 CRO 服务在全球范围内的普及主要是由于药物开发成本的上升、对日益复杂的治疗领域的专业知识的需求以及需要大量临床试验资料和文件的监管压力的增加。然而，资料安全和智慧财产权管理的潜在问题正在影响 CRO 的采用。围绕保密、智慧财产权和管治结构建立明确的合约协议对于解决这些问题至关重要。细胞和基因疗法等先进治疗方法的兴起，以及精准医学的发展，为 CRO 提供了开发专业服务的重大机会。在数位领域，透过采用人工智慧和机器学习进行资料分析并结合虚拟临床试验，预计将出现新的发展。

主要市场统计
基准年[2023] 887.8亿美元
预测年份 [2024] 982.8亿美元
预测年份 [2030] 1842.1亿美元
复合年增长率（%） 10.98%

聘请临床研究服务来管理型式临床试验的复杂性和持续时间

临床研究服务包括管理和进行临床试验，以测试新药、设备和治疗通讯协定，并确定其对人体的安全性和有效性。服务包括临床试验设计、病患招募、监管备案、地点选择、监测、以及资料收集和分析。 CRO提供的咨询服务包括有关药物开发路径、监管合规性和打入市场策略以及业务改善和财务规划的策略建议。资料管理服务包括临床试验期间收集的资料的收集、清理和分析。这包括使用电子资料采集 (EDC)、生物统计学和临床资料管理系统 (CDMS) 等先进技术。早期开发服务着重于药物开发的早期阶段，从发现到 I 期和 IIA 期试验。这包括药物化学、临床前研究、药物动力学和首次人体研究。这些服务对于需要专业知识将分子从实验室转移到临床试验的公司尤其重要。实验室服务是指为支持药物开发过程而进行的各种测试和分析，例如生物分析服务、临床试验的中心实验室服务和生物标记研究。

测试阶段：需要强大的真实资料和上市后支援的CRO

I期试验是人体试验的第一阶段，主要着重于评估药物的安全性、耐受性、药物动力学和动态。此阶段的服务包括设计和进行首次人体（FIH）试验、健康志愿者试验和早期患者试验。在二期试验中，重点转向确定药物的疗效并进一步评估其安全性，包括患者招募和入组策略、概念验证研究以及监管支持和提交。 III 期试验是大规模试验，通常在多个国家进行，旨在确认药物的有效性、监测副作用并将治疗方法进行比较。一旦药物获得核准并投放市场，第四期试验（也称为上市后监测）就开始监测药物的长期有效性以及对患者生活品质的影响。这里的关键服务包括风险管理和药物安全检测、评估长期有效性的註册研究以及市场准入和报销援助。

治疗领域：CRO服务一直是肿瘤药物开发的首选

心血管疾病 (CVD) 仍然是全球死亡的主要原因，因此需要专注于开发高血压、心臟衰竭和心律不整等疾病治疗方法的综合研究服务。 CVD 领域的 CRO 服务通常包括临床试验管理、病患招募和监管支援。由于从干癣到黑色素瘤等皮肤病的盛行率不断上升，皮肤病学领域正受到越来越多的关注。该领域所需的服务包括临床试验设计、患者报告的结果和生物统计学，主要关注皮肤病学终点。胃肠道 (GI) 疾病包括大肠激躁症、克隆氏症和大肠癌等多种疾病，需要专门从事胃肠道检测的 CRO 的专业知识。由于许多胃肠道疾病是慢性病，需要长期治疗，因此对此类服务的需求强劲。血液学是血液相关疾病的研究，需要专门的 CRO 服务来指导白血病、淋巴瘤、血友病等的复杂临床试验。随着加强治疗方法和开发根治性治疗方法的呼声日益高涨，对这些服务的需求也不断增加。类风湿性关节炎和狼疮等免疫性疾病的特征是慢性进展，需要熟练的免疫调节治疗服务。该领域非常需要针对特定疾病的研究设计和终点。随着新病原体的持续威胁和抗生素抗药性的发展，感染疾病领域对 CRO 服务的需求不断增加。这些服务包括疫苗开发、抗菌药物抗药性测试以及爱滋病毒、结核病和肝炎等疾病的治疗试验。阿兹海默症、多发性硬化症和帕金森氏症等神经系统疾病由于其复杂性和测量临床结果的困难而面临独特的挑战。能够克服这种复杂性的 CRO 服务（例如神经影像和神经认知评估）的需求量很大。肿瘤学是最具活力的领域之一，由于癌症的侵袭性和对创新治疗方法的持续需求，对 CRO 服务的需求持续高涨。服务范围从早期检测到后期临床试验，个人化医疗和免疫肿瘤学正受到越来越多的关注。

最终用户：学术研究机构强大的基础研究能力的需要

学术研究机构经常求助于 CRO 服务来加强其研究并利用专业技能，而无需支付内部基础设施的管理费用。他们的愿望通常与早期研究、教育资源和津贴资金筹措一致。医疗设备公司专注于医疗设备的开发、测试和商业化。与 CRO 的合作对于应对充满挑战的监管环境和管理多阶段试验至关重要。製药和生物技术公司是 CRO 的主要客户，因为它们需要整体的研发服务，从临床前测试到后期临床试验和上市后监测。

区域洞察

由于强大的製药和生物技术行业、严格的 FDA 法规以及对一致药物开发的重视，美洲尤其是美国对 CRO 服务的需求很高。这导致了经验丰富的 CRO 的集中，这些 CRO 拥有先进的基础设施、复杂临床试验的专业知识和端到端服务交付。由于其具有成本效益的营运、庞大且多样化的患者群体以及不断改善的法规环境，亚太地区正在迅速成为 CRO 服务的首选目的地。在该地区，中国、印度等国家已成为临床试验活动的热点，当地CRO的数量正在迅速增加。亚太地区的合约研究机构可能专注于数量主导的服务，但他们正在增加对品质和技术进步的投资，以在全球范围内竞争。欧洲凭藉丰富的药物研究历史、重要的法律规范和高技能的劳动力保持着强大的地位，吸引了遵守严格合规标准的复杂 CRO 活动。儘管中东和非洲的 CRO 服务仍在发展中，但由于不断增长的医疗保健投资以及开拓的多样化基因库，它们提供了商机。

FPNV定位矩阵

FPNV定位矩阵对于评估药物委外研发机构服务市场极为重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对委外研发机构服务市场中供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.药物委外研发机构服务市场的市场规模和预测是多少？

2.在药物委外研发机构服务市场的预测期内，需要考虑投资的产品、细分市场、应用和领域有哪些？

3.药物委外研发机构服务市场的技术趋势和法规结构是什么？

4.药品委外研发机构服务市场主要厂商的市场占有率是多少？

5.进入药物委外研发机构服务市场的适当型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 加大医药研发投入
      • 生技药品和核子医学的普及
      • 研究活动中越来越多采用外包服务
    • 抑制因素
      • 资料管理和完整性问题
    • 机会
      • CRO引进数位化、敏捷製造/研发技术
      • 专注于更先进的细胞和基因疗法的新临床试验设计和通讯协定
    • 任务
      • 临床研究中的病患招募与保留问题
  • 市场区隔分析
    • 类型：实施临床研究服务以管理临床试验的复杂性和持续时间
    • 实验阶段：需要具有强大真实资料和上市后支援能力的CRO
    • 治疗领域：CRO服务在肿瘤药物开发活动中的一贯优先地位
    • 最终用户：需要学术和研究机构强大的基础研究能力
  • 市场趋势分析
    • 政府对药物研发的大力支持以及遍布美洲的专门从事肿瘤学的 CRO 的存在
    • 凭藉强大的药品製造能力以及战略合作伙伴关係和收购，扩大 CRO 在亚太地区的地理覆盖范围。
    • 欧洲、中东和非洲全部区域不断增长的医药品研究开发费用、复杂的法规环境以及不断增长的合作伙伴关係
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析

第六章 药品委外研发机构服务市场：依类型

  • 临床研究服务
  • 咨询服务
  • 资料管理服务
  • 早期开发服务
  • 化验服务

第七章 药品委外研发机构服务市场试行阶段

  • 第一阶段
  • 第二阶段
  • 第三阶段
  • 第四阶段

第八章依治疗领域分類的药物委外研发机构服务市场

  • 循环系统疾病
  • 皮肤科
  • 胃
  • 泌尿系统和女性健康
  • 血液学
  • 免疫疾病
  • 感染疾病
  • 代谢疾病/内分泌学
  • 神经病学
  • 肿瘤学
  • 眼科
  • 精神病学
  • 呼吸系统疾病

第九章按分子类型分類的药物委外研发机构服务市场

  • 细胞和基因治疗疾病
  • 疫苗

第十章 药品委外研发机构服务市场：依最终用户分类

  • 学术机构
  • 医疗设备公司
  • 製药和生物技术公司

第十一章：美洲药物委外研发机构服务市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章 亚太地区药物委外研发机构服务市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章 欧洲/中东/非洲药品委外研发机构服务市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
    • Vida Clinical Research 透过策略收购欧洲 CRO 加强全球影响力
    • EUROAPI 和 SpiroChem 之间的创新合作彻底改变了药物开发中的 CRO-CDMO 整合
    • Maridose 成立创新型 CRO 团队进行大麻药物开发
    • Julius Clinical Research 获得 Ampersand Capital Partners 的成长投资
    • Everest Clinical Research 宣布收购 August Research
    • PRC Clinical 与 TrialHub 合作提高临床试验效率和患者招募
    • OrganaBio 推出创新的细胞处理和冷冻保存服务以支持分散的临床试验
    • MedRhythms 选择 Curavit 作为慢性中风分散临床试验的合约研究组织 (CRO)
    • 透过与世界各地的临床试验和所有治疗方法的策略合作伙伴关係来创新医疗保健
    • ClinChoice 透过策略收购 CROMSOURCE 扩大全球影响力
    • Avanir 收购 Maxis：加强医疗技术开发和商业化
    • TFS Health Sciences 透过收购 Apple Tree CI Group 拓展视野

第15章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-5012464360F9

[188 Pages Report] The Contract Research Organization Services Market size was estimated at USD 88.78 billion in 2023 and expected to reach USD 98.28 billion in 2024, at a CAGR 10.98% to reach USD 184.21 billion by 2030.

Contract research organization (CRO) services encompass a range of outsourced support options provided to pharmaceutical, biotechnology, and medical device industries for drug development, clinical trial management, and post-marketing surveillance. These organizations offer expertise in regulatory submission guidance, clinical operations, data management, statistical analysis, medical writing, and other functions necessary to navigate the complex processes of bringing a medical product to market. The global proliferation of CRO services is mainly driven by the escalating costs of drug development, the need for specialized knowledge in increasingly complex therapeutic areas, and mounting regulatory pressures that require extensive clinical trial data and documentation. However, potential issues with data security and management of intellectual property impact their adoption. Establishing clear contractual agreements delineating confidentiality obligations, IP rights, and governance structures is essential to address these concerns. The rise of advanced therapies like cell and gene therapies, along with the growth of precision medicine, presents a substantial opportunity for CROs to develop specialized services. In the digital realm, the employment of artificial intelligence and machine learning for data analysis and the incorporation of virtual clinical trials are trends expected to offer new avenues for expansion.

KEY MARKET STATISTICS
Base Year [2023] USD 88.78 billion
Estimated Year [2024] USD 98.28 billion
Forecast Year [2030] USD 184.21 billion
CAGR (%) 10.98%

Type: Adoption of clinical research services to manage the complexity and duration of clinical trials

Clinical research services involve the management and execution of clinical trials to test new drugs, devices, and treatment protocols to determine their safety and efficacy in humans. Services include trial design, patient recruitment, regulatory submissions, site selection, monitoring, and data collection and analysis. Consulting services by CROs involve strategic advice on drug development pathways, regulatory compliance, and market entry strategies, and they also extend to operational improvements and financial planning. Data management services encompass the collection, cleaning, and analysis of data gathered during clinical trials. This includes the use of advanced technologies such as electronic data capture (EDC), biostatistics, and clinical data management systems (CDMS). Early phase development services are focused on the initial stages of drug development, from drug discovery through Phase I and Phase IIA studies. This includes medicinal chemistry, preclinical studies, pharmacokinetics, and first-in-human trials. These services are particularly relevant for companies that require specialized expertise in transitioning a molecule from the lab to clinical testing. Laboratory services refer to a range of tests and analyses conducted in support of the drug development process, including bioanalytical services, central lab services for clinical trials, and biomarker studies.

Trial Phase: Need for CROs with strong capabilities in real-world data and post-market support

Phase I trials are the first stage of testing in human subjects and primarily focus on assessing the safety, tolerability, pharmacokinetics, and pharmacodynamics of a drug. Services in this phase include first-in-human (FIH) trial design and execution, healthy volunteer studies, and early-stage patient trials, among others. In Phase II, the focus shifts towards determining the efficacy of the drug and further evaluating its safety, including patient recruitment and enrollment strategies, proof-of-concept studies, and regulatory support and filings. Phase III trials involve large-scale studies, often multinational, to confirm the drug's efficacy, monitor side effects, and compare it with standard or equivalent treatments. Once a drug is approved and marketed, Phase IV studies, also known as post-marketing surveillance, are initiated to monitor the drug's long-term effectiveness and impact on the patient's quality of life. Key services here include risk management and pharmacovigilance, registry studies to assess long-term effects, and market access and reimbursement support.

Therapeutic Area: Consistent preference for CRO services in oncology drug development activities

Cardiovascular diseases (CVD) remain a major cause of mortality globally, driving the need for comprehensive research services focusing on the development of treatments for conditions such as hypertension, heart failure, and arrhythmias. CRO services for CVD often include clinical trial management, patient recruitment, and regulatory support. The dermatology sector is increasingly attracting attention due to the rising prevalence of skin disorders ranging from psoriasis to melanoma. Services required in this area predominantly encompass clinical trial design specific to dermatological endpoints, patient-reported outcomes, and biostatistics. Gastrointestinal (GI) disorders include a wide range of conditions, such as irritable bowel syndrome, Crohn's disease, and colorectal cancer, requiring the expertise of CROs specialized in GI studies. Demand for such services is strong due to the chronic nature of many GI diseases and the necessity for long-term treatment regimens. Hematology, the study of blood-related diseases, demands specialized CRO services to navigate complex clinical trials for conditions like leukemia, lymphoma, and hemophilia. These services are in high demand as the quest to enhance treatment regimens and develop curative therapies intensifies. Immunological disorders, such as rheumatoid arthritis and lupus, are marked by chronic progression and require services that are adept at handling immune-modulating treatments. This segment reveals a strong preference for disease-specific trial designs and endpoints. With the continuous threat of emerging pathogens and the development of antibiotic resistance, there is a substantial need for CRO services within infectious diseases. These services include vaccine development, antimicrobial resistance studies, and treatment trials for diseases, including HIV, tuberculosis, and hepatitis. Neurological conditions, such as Alzheimer's disease, multiple sclerosis, and Parkinson's disease, pose unique challenges due to their complexity and the difficulty in measuring clinical outcomes. CRO services that can navigate this complexity, including neuroimaging and neurocognitive assessments, are in high demand. Oncology is one of the most dynamic segments with a persistently high demand for CRO services due to the aggressive nature of cancer and the ongoing need for innovative therapies. Services span early-stage discovery to late-stage clinical trials, with an increasing focus on personalized medicine and immuno-oncology.

End-User: Need for strong foundational research capabilities by academic and research institutions

Academic Institutes often engage CRO services to bolster research without the overhead costs of internal infrastructure and to access specialized skill sets. Their preferences are generally aligned with early-phase research, educational resources, and grant-based funding integration. Medical device companies focus on the development, testing, and commercialization of medical devices. CRO partnerships are vital in navigating the stringent regulatory landscape and managing multi-phase trials. Pharmaceutical and Biotechnology firms are the primary clients for CROs due to their extensive need for full-spectrum research and development services ranging from preclinical studies to late-stage clinical trials and post-marketing surveillance.

Regional Insights

In the Americas, particularly the United States, there is a high demand for CRO services owing to a substantial pharmaceutical and biotechnology sector, stringent FDA regulations, and a consistent emphasis on drug development. This results in a concentration of seasoned CROs equipped with advanced infrastructure, expertise in complex clinical trials, and end-to-end service offerings. The APAC region is rapidly emerging as a favorable destination for CRO services, owing to its cost-effective operations, large and diverse patient population, and improving regulatory environment. This region has seen a surge in local CROs, with countries such as China and India becoming hotspots for clinical trial activities. APAC's CROs may focus on volume-driven services but are increasingly investing in quality and technological advancements to compete on a global level. Europe maintains a strong position with a rich history of pharmaceutical research, a key regulatory framework, and a highly skilled workforce, attracting CRO activities that are sophisticated and adhere to strict compliance standards. The Middle East and Africa, though still nascent in terms of CRO services, offer opportunities due to growing healthcare investments and untapped diverse genetic pools.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Contract Research Organization Services Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Contract Research Organization Services Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Contract Research Organization Services Market, highlighting leading vendors and their innovative profiles. These include AccuLab Life Sciences, ACTIVA-CRO, Advanced Clinical Research Services, LLC, BioAgile Therapeutics Pvt. Ltd., Caidya, Calian Group Ltd., Celerion, Inc., Charles River Laboratories International, Inc., Clinical Trial Service B.V. by PCM Trials, Cromsource by ClinChoice, CTI Clinical Trial & Consulting, Distefar del Sur SL, Ergomed PLC, Firma Clinical Research, LLC, Frontage Holdings Corporation, Geistek Pharma S.L., HCL Technologies Limited, Icon PLC, INQUIS, IQVIA Holdings Inc., KCR S.A., Laboratory Corporation of America Holdings, Leon Research, S.L., Linical Co., Ltd., Medpace Holdings, Inc., Novotech Health Holdings, OPIS S.r.l., Oxon Epidemiology, S.L., Parexel International Corporation, Pepgra, Pharmaron Beijing Co., Ltd., Pivotal, S.L.U., PPD Inc. by Thermo Fisher Scientific Inc., Prometrika, LLC, ProRelix Services LLP, PSI CRO AG, QualitecFarma S.L., SGS S.A., Syncro Clinical Research SRL, Syneos Health, Inc., The Emmes Company, LLC, Veeda Clinical Research Limited, Vial Health Technology, Inc., Worldwide Clinical Trials Holdings Inc., WuXi AppTec Co., Ltd., and X7 Research.

Market Segmentation & Coverage

This research report categorizes the Contract Research Organization Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Clinical Research Services
    • Consulting Services
    • Data Management Services
    • Early Phase Development Services
      • Chemistry, Manufacturing & Control
      • Discovery Studies
      • Preclinical Services
        • Pharmacokinetics/Pharmacodynamics
        • Toxicology Testing
    • Laboratory Services
      • Analytical Testing
        • Batch Release Testing
        • Physical Characterization
        • Raw Material Testing
        • Stability Testing
      • Bioanalytical Testing
  • Trial Phase
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
  • Therapeutic Area
    • Cardiovascular Disease
    • Dermatology
    • Gastrointestinal
    • Genitourinary & Women's Health
    • Hematology
    • Immunological Disorders
    • Infectious Diseases
    • Metabolic Disorders/Endocrinology
    • Neurology
    • Oncology
    • Ophthalmology
    • Psychiatry
    • Respiratory Disorders
  • Molecule Type
    • Cell & Gene Therapy Diseases
    • Vaccines
  • End-User
    • Academic Institutes
    • Medical Device Companies
    • Pharmaceutical & Biotechnology Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Contract Research Organization Services Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Contract Research Organization Services Market?

3. What are the technology trends and regulatory frameworks in the Contract Research Organization Services Market?

4. What is the market share of the leading vendors in the Contract Research Organization Services Market?

5. Which modes and strategic moves are suitable for entering the Contract Research Organization Services Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing investments in pharmaceutical research and development
      • 5.1.1.2. Growing penetration of biologics and nuclear medicines
      • 5.1.1.3. Rise in adoption of outsourced services for research activities
    • 5.1.2. Restraints
      • 5.1.2.1. Concerns associated with data management and integrity
    • 5.1.3. Opportunities
      • 5.1.3.1. Adoption of digitized and agile manufacturing and research development techniques by CROs
      • 5.1.3.2. Emphasis on novel clinical trial designs and protocols for more advanced cell and gene therapy
    • 5.1.4. Challenges
      • 5.1.4.1. Issues of patient recruitment and retention for clinical research
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Adoption of clinical research services to manage the complexity and duration of clinical trials
    • 5.2.2. Trial Phase: Need for CROs with strong capabilities in real-world data and post-market support
    • 5.2.3. Therapeutic Area: Consistent preference for CRO services in oncology drug development activities
    • 5.2.4. End-User: Need for strong foundational research capabilities by academic and research institutions
  • 5.3. Market Trend Analysis
    • 5.3.1. Substantial government support for pharmaceutical R&D, along with the presence of CROs specializing in oncology across the Americas
    • 5.3.2. Robust pharmaceutical manufacturing capabilities and strategic partnerships and acquisitions to expand the geographical footprint of CROs in the APAC region
    • 5.3.3. Increased pharmaceutical R&D expenditure, complex regulatory environments, and expanding partnerships across the EMEA region
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework Analysis

6. Contract Research Organization Services Market, by Type

  • 6.1. Introduction
  • 6.2. Clinical Research Services
  • 6.3. Consulting Services
  • 6.4. Data Management Services
  • 6.5. Early Phase Development Services
  • 6.6. Laboratory Services

7. Contract Research Organization Services Market, by Trial Phase

  • 7.1. Introduction
  • 7.2. Phase I
  • 7.3. Phase II
  • 7.4. Phase III
  • 7.5. Phase IV

8. Contract Research Organization Services Market, by Therapeutic Area

  • 8.1. Introduction
  • 8.2. Cardiovascular Disease
  • 8.3. Dermatology
  • 8.4. Gastrointestinal
  • 8.5. Genitourinary & Women's Health
  • 8.6. Hematology
  • 8.7. Immunological Disorders
  • 8.8. Infectious Diseases
  • 8.9. Metabolic Disorders/Endocrinology
  • 8.10. Neurology
  • 8.11. Oncology
  • 8.12. Ophthalmology
  • 8.13. Psychiatry
  • 8.14. Respiratory Disorders

9. Contract Research Organization Services Market, by Molecule Type

  • 9.1. Introduction
  • 9.2. Cell & Gene Therapy Diseases
  • 9.3. Vaccines

10. Contract Research Organization Services Market, by End-User

  • 10.1. Introduction
  • 10.2. Academic Institutes
  • 10.3. Medical Device Companies
  • 10.4. Pharmaceutical & Biotechnology Companies

11. Americas Contract Research Organization Services Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Contract Research Organization Services Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Contract Research Organization Services Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Veeda Clinical Research Bolsters Global Presence with Strategic Acquisition of European CRO, Heads
    • 14.3.2. Innovative Partnership between EUROAPI and SpiroChem Revolutionizes CRO-CDMO Integration for Drug Development
    • 14.3.3. Maridose Launches Innovative CRO Group for Cannabis-Based Drug Development
    • 14.3.4. Julius Clinical Research Receives Growth Investment from Ampersand Capital Partners
    • 14.3.5. Everest Clinical Research Announces the Acquisition of August Research
    • 14.3.6. PRC Clinical and TrialHub Unite to Elevate Clinical Trial Efficiency and Patient Recruitment
    • 14.3.7. OrganaBio Launches Innovative Cell Processing and Cryopreservation Services to Support Decentralized Clinical Trials
    • 14.3.8. MedRhythms Choses Curavit as its Contract Research Organization (CRO) for a Chronic Stroke Decentralized Clinical Trial
    • 14.3.9. Innovating Healthcare through a Strategic Partnership between Worldwide Clinical Trials and Every Cure
    • 14.3.10. ClinChoice Expands Global Reach with Strategic Acquisition of CROMSOURCE
    • 14.3.11. Avania Acquires MAXIS: Enhancing Medtech Development and Commercialization
    • 14.3.12. TFS HealthScience Broadens Its Horizons with Appletree CI Group Acquisition

15. Competitive Portfolio

  • 15.1. Key Company Profiles
  • 15.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. CONTRACT RESEARCH ORGANIZATION SERVICES MARKET RESEARCH PROCESS
  • FIGURE 2. CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CONTRACT RESEARCH ORGANIZATION SERVICES MARKET DYNAMICS
  • FIGURE 7. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 20. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 26. CONTRACT RESEARCH ORGANIZATION SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY CLINICAL RESEARCH SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY CONSULTING SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY DATA MANAGEMENT SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY DATA MANAGEMENT SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY CHEMISTRY, MANUFACTURING & CONTROL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY CHEMISTRY, MANUFACTURING & CONTROL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY DISCOVERY STUDIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY DISCOVERY STUDIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHARMACOKINETICS/PHARMACODYNAMICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHARMACOKINETICS/PHARMACODYNAMICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY BATCH RELEASE TESTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY BATCH RELEASE TESTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHYSICAL CHARACTERIZATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHYSICAL CHARACTERIZATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY RAW MATERIAL TESTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY RAW MATERIAL TESTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY STABILITY TESTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY STABILITY TESTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY BIOANALYTICAL TESTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY BIOANALYTICAL TESTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHASE I, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHASE I, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHASE II, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHASE II, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHASE III, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHASE III, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHASE IV, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHASE IV, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 64. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY DERMATOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 65. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 66. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 67. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY GENITOURINARY & WOMEN'S HEALTH, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 68. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY GENITOURINARY & WOMEN'S HEALTH, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 69. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 70. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY HEMATOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 71. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 72. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 73. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 74. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 75. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY METABOLIC DISORDERS/ENDOCRINOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 76. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY METABOLIC DISORDERS/ENDOCRINOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 77. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 78. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY NEUROLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 79. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 80. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 81. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 82. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 83. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PSYCHIATRY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 84. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PSYCHIATRY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 85. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 86. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 87. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
  • TABLE 88. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
  • TABLE 89. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY CELL & GENE THERAPY DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 90. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY CELL & GENE THERAPY DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 91. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY VACCINES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 92. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY VACCINES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 93. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 94. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 95. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 96. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 97. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 98. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 99. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 100. GLOBAL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 101. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 102. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 103. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2023 (USD MILLION)
  • TABLE 104. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2024-2030 (USD MILLION)
  • TABLE 105. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2023 (USD MILLION)
  • TABLE 106. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2024-2030 (USD MILLION)
  • TABLE 107. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 108. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 109. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2023 (USD MILLION)
  • TABLE 110. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2024-2030 (USD MILLION)
  • TABLE 111. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2023 (USD MILLION)
  • TABLE 112. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2024-2030 (USD MILLION)
  • TABLE 113. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 114. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 115. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 118. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 119. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 120. AMERICAS CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 121. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2023 (USD MILLION)
  • TABLE 124. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2024-2030 (USD MILLION)
  • TABLE 125. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2023 (USD MILLION)
  • TABLE 126. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2024-2030 (USD MILLION)
  • TABLE 127. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 128. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 129. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2023 (USD MILLION)
  • TABLE 130. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2024-2030 (USD MILLION)
  • TABLE 131. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2023 (USD MILLION)
  • TABLE 132. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2024-2030 (USD MILLION)
  • TABLE 133. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 134. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 135. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
  • TABLE 136. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
  • TABLE 137. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 138. ARGENTINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 139. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2023 (USD MILLION)
  • TABLE 142. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2024-2030 (USD MILLION)
  • TABLE 143. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2023 (USD MILLION)
  • TABLE 144. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2024-2030 (USD MILLION)
  • TABLE 145. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 146. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 147. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2023 (USD MILLION)
  • TABLE 148. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2024-2030 (USD MILLION)
  • TABLE 149. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2023 (USD MILLION)
  • TABLE 150. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2024-2030 (USD MILLION)
  • TABLE 151. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 152. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 153. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
  • TABLE 154. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
  • TABLE 155. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 156. BRAZIL CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 157. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 158. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 159. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2023 (USD MILLION)
  • TABLE 160. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2024-2030 (USD MILLION)
  • TABLE 161. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2023 (USD MILLION)
  • TABLE 162. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2024-2030 (USD MILLION)
  • TABLE 163. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 164. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 165. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2023 (USD MILLION)
  • TABLE 166. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2024-2030 (USD MILLION)
  • TABLE 167. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2023 (USD MILLION)
  • TABLE 168. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2024-2030 (USD MILLION)
  • TABLE 169. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 170. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 171. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 174. CANADA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 175. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 176. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 177. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2023 (USD MILLION)
  • TABLE 178. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2024-2030 (USD MILLION)
  • TABLE 179. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2023 (USD MILLION)
  • TABLE 180. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2024-2030 (USD MILLION)
  • TABLE 181. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 182. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 183. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2023 (USD MILLION)
  • TABLE 184. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2024-2030 (USD MILLION)
  • TABLE 185. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2023 (USD MILLION)
  • TABLE 186. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2024-2030 (USD MILLION)
  • TABLE 187. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 188. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 189. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 192. MEXICO CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 193. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 194. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 195. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2023 (USD MILLION)
  • TABLE 196. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2024-2030 (USD MILLION)
  • TABLE 197. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2023 (USD MILLION)
  • TABLE 198. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2024-2030 (USD MILLION)
  • TABLE 199. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 200. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 201. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2023 (USD MILLION)
  • TABLE 202. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2024-2030 (USD MILLION)
  • TABLE 203. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2023 (USD MILLION)
  • TABLE 204. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2024-2030 (USD MILLION)
  • TABLE 205. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 206. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 207. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
  • TABLE 208. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
  • TABLE 209. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 210. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 211. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 212. UNITED STATES CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2023 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2024-2030 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2023 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2024-2030 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 221. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2023 (USD MILLION)
  • TABLE 222. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2024-2030 (USD MILLION)
  • TABLE 223. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2023 (USD MILLION)
  • TABLE 224. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2024-2030 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 233. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 234. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 235. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2023 (USD MILLION)
  • TABLE 236. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2024-2030 (USD MILLION)
  • TABLE 237. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2023 (USD MILLION)
  • TABLE 238. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2024-2030 (USD MILLION)
  • TABLE 239. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 240. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 241. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2023 (USD MILLION)
  • TABLE 242. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2024-2030 (USD MILLION)
  • TABLE 243. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2023 (USD MILLION)
  • TABLE 244. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2024-2030 (USD MILLION)
  • TABLE 245. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 246. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 247. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
  • TABLE 248. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
  • TABLE 249. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 250. AUSTRALIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 251. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 252. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 253. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2023 (USD MILLION)
  • TABLE 254. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2024-2030 (USD MILLION)
  • TABLE 255. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-2023 (USD MILLION)
  • TABLE 256. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2024-2030 (USD MILLION)
  • TABLE 257. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 258. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY LABORATORY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 259. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2018-2023 (USD MILLION)
  • TABLE 260. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY ANALYTICAL TESTING, 2024-2030 (USD MILLION)
  • TABLE 261. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2018-2023 (USD MILLION)
  • TABLE 262. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TRIAL PHASE, 2024-2030 (USD MILLION)
  • TABLE 263. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2023 (USD MILLION)
  • TABLE 264. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2024-2030 (USD MILLION)
  • TABLE 265. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2018-2023 (USD MILLION)
  • TABLE 266. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY MOLECULE TYPE, 2024-2030 (USD MILLION)
  • TABLE 267. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 268. CHINA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 269. INDIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 270. INDIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 271. INDIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2018-2023 (USD MILLION)
  • TABLE 272. INDIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY EARLY PHASE DEVELOPMENT SERVICES, 2024-2030 (USD MILLION)
  • TABLE 273. INDIA CONTRACT RESEARCH ORGANIZATION SERVICES MARKET SIZE, BY PRECLINICAL SERVICES, 2018-